Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 21, 2007; 13(35): 4761-4770
Published online Sep 21, 2007. doi: 10.3748/wjg.v13.i35.4761
Published online Sep 21, 2007. doi: 10.3748/wjg.v13.i35.4761
Table 2 Cell cycle analysis (mean ± SD, %)
| MZ-CHA-2 | EGI-1 | |||||
| G0/G1 | S | G2/M | G0/G1 | S | G2/M | |
| CTRL | 38.3 ± 3 | 44.7 ± 3 | 17.0 ± 3 | 58.7 ± 5 | 29.2 ± 2 | 12.1 ± 1 |
| LAQ824 (25 nmol/L) | 37.0 ± 1 | 42.8 ± 2 | 20.1 ± 2 | 50.1 ± 7 | 31.9 ± 4 | 18.1 ± 3 |
| LAQ824 (50 nmol/L) | 36.9 ± 2 | 38.7 ± 5 | 24.4 ± 4 | 41.2 ± 2 | 34.8 ± 2 | 24.1 ± 4 |
| LBH589 (25 nmol/L) | 35.5 ± 1 | 27.6 ± 3 | 36.9 ± 2 | 38.8 ± 5 | 33.8 ± 3 | 27.4 ± 4 |
| LBH589 (50 nmol/L) | 38.8 ± 2 | 9.0 ± 3 | 52.3 ± 2 | 46.0 ± 1 | 15.1 ± 2 | 38.9 ± 1 |
- Citation: Bluethner T, Niederhagen M, Caca K, Serr F, Witzigmann H, Moebius C, Mossner J, Wiedmann M. Inhibition of histone deacetylase for the treatment of biliary tract cancer: A new effective pharmacological approach. World J Gastroenterol 2007; 13(35): 4761-4770
- URL: https://www.wjgnet.com/1007-9327/full/v13/i35/4761.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i35.4761